Innovators in Discovery
Charles L. Sawyers, MD, FAACR, co-developed Gleevec, among the first targeted cancer therapies, and is set on understanding prostate cancer drug resistance.
David A. Tuveson, MD, PhD, FAACR, has centered his clinical and research work on pancreatic cancer, a disease that is frustratingly resistant to treatment.
Anna D. Barker, PhD, FAACR, does not shy away from large projects undertaken to advance cancer science. Cancer first entered Dr. Barker’s world as a child, watching her grandparents, parents, and sister face cancer diagnoses.
Elaine R. Mardis, PhD, spends a lot of her time studying molecules at the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio.
Not many people can say they’ve won a Nobel Prize and been featured on the side of a jetliner with Avengers superheroes. Phillip A. Sharp, PhD, can check both boxes. And that’s just a small sample of Dr. Sharp's many extraordinary achievements.
Five decades after she read the biography of Dr. Marie Curie, AACR Past President Elizabeth M. Jaffee, MD, FAACR, strives to follow in the footsteps of her role model.
Physician-scientist and Fellow of the AACR Academy William N. Hait, MD, PhD, encourages collaborations to intercept, prevent, and treat cancer. Throughout a varied career in academia and industry, Dr. Hait has kept his sights on benefiting patients.
Dr. Olufunmilayo Olopade, a physician-scientist and director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer.
As a physician scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now